Scleroderma pregnancy: can the price be too high to pay?
Ostensen, M.
Clinical and Experimental Rheumatology 26(6): 979-981
2008
ISSN/ISBN: 0392-856X PMID: 19210858 Document Number: 616218
Document emailed within 1 workday
Related Documents
Ziegler, V.; Haustein, U.F.; Mehlhorn, J.; Münzberger, H.; Rennau, H. 1986: Quartz-induced scleroderma. Scleroderma-like syndrome or true progressive scleroderma? Dermatologische Monatschrift 172(2): 86-90Maymon, R.; Fejgin, M.; Ben-Aderet, N.; Bahary, C. 1989: Scleroderma and pregnancy Acta Obstetricia et Gynecologica Scandinavica 68(5): 469-470
Karlen, J.R.; Cook, W.A. 1974: Renal scleroderma and pregnancy Obstetrics and Gynecology 44(3): 349-354
Panis, Y. 2004: Surgical treatment of rectal cancer: is the price to be paid too high? Gastroenterologie Clinique et Biologique 28(2): 153-154
2004: Strategic price setting: ensuring your financial viability through price modeling Healthcare financial management: journal of the Healthcare Financial Management Association 58(7): 1-7
Elmes, J.; Nhongo, K.; Ward, H.; Hallett, T.; Nyamukapa, C.; White, P.J.; Gregson, S. 2014: The price of sex: condom use and the determinants of the price of sex among female sex workers in eastern Zimbabwe Journal of Infectious Diseases 210(Suppl 2): S569-S578
Morrow, T. 2013: Do comparable efficacy and convenient dosing justify Procysbi's extremely high price? Managed Care 22(7): 71-72
Ejd, M. 1992: New legislation on forced psychiatric care. Increased integrity is good but the price can be too high Vardfacket 16(8): 24-25
Burda, D. 1993: Drugmakers' price plan ruled to be price-fixing by agency Modern Healthcare 23(41): 8
Gardner, E. 2006: Making the cut. High price tags for state-of-the art surgical equipment have hospitals weighing when or even whether to invest Modern Healthcare 36(7): 50
Guillaumier, A.; Bonevski, B.; Paul, C.; D'Este, C.; Doran, C.; Siahpush, M. 2014: Paying the price: a cross-sectional survey of Australian socioeconomically disadvantaged smokers' responses to hypothetical cigarette price rises Drug and Alcohol Review 33(2): 177-185
Ishikawa, H.; Suzuki, S.; Horiuchi, R.; Sato, H. 1975: An approach to experimental scleroderma, using urinary glycosaminoglycans from patients with systemic scleroderma Acta Dermato-Venereologica 55(2): 97-107
Giordano, M.; Valenti, G. 1986: Linear scleroderma plus systemic sclerosis sine scleroderma plus neuromyopathy of one upper limb: a new entity? Journal of Rheumatology 13(3): 656-657
De la Espriella, J.; Crickx, B. 1991: Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs Annales de Dermatologie et de Venereologie 118(12): 948-953
Pope, J.E.; Bellamy, N. 1995: Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials Clinical and Investigative Medicine 18(1): 1-10
Jablonska, S.; Blaszczyk, M. 1999: Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis European Journal of Dermatology: Ejd 9(7): 551-554
Kochetov, D.P.; Krivosheev, B.N. 1976: Scleroderma and porphyria cutanea tarda with clinical manifestations of scleroderma Vestnik Dermatologii i Venerologii 1: 64-68
Madsen, K.L.; Hansen, A.; Halberg, P.; Ullman, S. 2014: Development of scleroderma renal crisis in a patient with undiagnosed scleroderma Ugeskrift for Laeger 176(25a)
Black, C.M. 1994: Prognosis and management of scleroderma and scleroderma-like disorders in children Clinical and Experimental Rheumatology 12(Suppl 10): S75-S81
Haustein, U.F.; Ziegler, V. 1986: Scleroderma and scleroderma-like diseases caused by environmental pollutants Dermatosen in Beruf und Umwelt. Occupation and Environment 34(3): 61-67